Zobrazeno 1 - 6
of 6
pro vyhledávání: '"José Ponce Lorenzo"'
Autor:
Antonio Llombart-Cussac, José Manuel Pérez-Garcia, Manuel Ruiz Borrego, Pablo Tolosa, Salvador Blanch, Adela Fernández-Ortega, Ander Urruticoechea, Isabel Blancas, Cristina Saura, Beatriz Rojas, Begoña Bermejo, José Ponce Lorenzo, María Gion, Patricia Cortez-Castedo, Elisenda Llabres, Elena Galve, Juan Fernando Cueva, Ana López, José Luis Alonso-Romero, Santiago González-Santiago, Eduardo Martínez de Dueñas, Eva Ciruelos, Griselda Martrat, Petra Gener, Daniel Alcalá-López, Miguel Sampayo-Cordero, Fernando Gómez-Peralta, Javier Cortés
Publikováno v:
EClinicalMedicine, Vol 71, Iss , Pp 102520- (2024)
Summary: Background: Hyperglycaemia is an early and frequent adverse event during alpelisib treatment. METALLICA aimed to evaluate prophylactic metformin to prevent or reduce hyperglycaemia occurrence in patients with HR+/HER2−/PIK3CA-mutated advan
Externí odkaz:
https://doaj.org/article/c5ba8bd9a6864624b463e00529accd71
Autor:
Joaquín Montalar Salcedo, José Ponce Lorenzo, Ángel Guerrero Zotano, Lorena Pellín Ariño, Ángel Segura Huerta, Jorge Molina Saera, Laura Palomar Abad
Publikováno v:
Clinical and Translational Oncology. 7:55-59
Los carcinomas microciticos extrapulmonares (CMEP) se han reconocido como entidad diferenciada del carcinoma microcitico broncopulmonar (CMBP). Se consideran una enfermedad sistemica desde el inicio y esto hace que su abordaje sea similar al de los C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee33fbdcc7fd6095a2cce7d3947a8073
https://doi.org/10.1007/bf02710010
https://doi.org/10.1007/bf02710010
Autor:
José Ponce Lorenzo, Alejandra Giménez Ortiz, Ángel Segura Huerta, Laura Palomar Abad, Gaspar Reynés Muntaner, Jorge Molina Saera
Publikováno v:
Clinical and Translational Oncology. 7:127-129
Oligodendrogliomas are primary brain tumours derived from oligodendroglial cells, or precursors, and represent 2%–5% of brain tumours. This type of glioma has a favourable prognosis compared to other brain tumours. The treatment is multidisciplinar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af288088b66f354011ef40b1196744be
https://doi.org/10.1007/bf02708746
https://doi.org/10.1007/bf02708746
Autor:
Joaquín Montalar Salcedo, Laura Palomar Abad, José Ponce Lorenzo, Roberto Díaz Beveridge, Alejandra Giménez Ortiz, Jorge Molina Saera, Jorge Aparicio Urtasun
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 8(8)
Recent studies have suggested a rise in the incidence of testicular germ-cell tumors (TGTs) in the last years, mainly due to an increase of early stage cases. We analysed the time trends in biological features of these patients in order to confirm th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e010fd1c32dfe7f8fea334c02ddbca7
https://pubmed.ncbi.nlm.nih.gov/16952847
https://pubmed.ncbi.nlm.nih.gov/16952847
Autor:
Jorge, Molina Saera, Angel, Segura Huerta, Laura, Palomar Abad, Alejandra, Giménez Ortiz, José, Ponce Lorenzo, Gaspar, Reynés Muntaner
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 7(3)
Oligodendrogliomas are primary brain tumours derived from oligodendroglial cells, or precursors, and represent 2%-5% of brain tumours. This type of glioma has a favourable prognosis compared to other brain tumours. The treatment is multidisciplinary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::80a82fa976d0d17a94c486eaf9727501
https://pubmed.ncbi.nlm.nih.gov/15899221
https://pubmed.ncbi.nlm.nih.gov/15899221
Autor:
Angel, Guerrero Zotano, Angel, Segura Huerta, Lorena, Pellín Ariño, Laura, Palomar Abad, Jorge, Molina Saera, José, Ponce Lorenzo, Joaquín, Montalar Salcedo
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 7(2)
Extra-pulmonary small cell carcinoma (ESCC) is as a pathologic entity distinct from small cell lung carcinoma (SCLC). ESCC is considered a systemic disease in its origin, so the therapeutic approach is similar to SCLC with chemotherapy being consider
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ce16a5076cf02dd298b23453edcdc094
https://pubmed.ncbi.nlm.nih.gov/15899209
https://pubmed.ncbi.nlm.nih.gov/15899209